Deals this week: Sientra, Advanced Bifurcation Systems, Spirosure

12 January 2018 (Last Updated January 12th, 2018 09:09)

Sientra Inc plans to raise $150m through a public offering of shares of its common stock and has filed a registration agreement for the same with the US Securities and Exchange Commission (SEC).

Sientra Inc plans to raise $150m through a public offering of shares of its common stock and has filed a registration agreement for the same with the US Securities and Exchange Commission (SEC).

The US-based medical aesthetics company plans to use the funds for working capital and other general corporate purposes.

US-based clinical-stage company Advanced Bifurcation Systems Inc plans to raise $20m through a private placement.

The placement is planned to be subscribed to by outside investors.

Spirosure Inc has raised $15m in a series C-2 financing round led by NGK Spark Plug Co Ltd.

Spirosure is a US-based developer of the Fenom PRO Point-of-Care Breath Analyzer. The company plans to use the funds towards sales and regulatory activities in Europe, China, and Japan.

Indian stent manufacturing company Sahajanand Medical Technologies Pvt Ltd has raised Rs2.5bn ($39.3m) through a private equity financing round led by Morgan Stanley Private Equity Asia and Samara Capital Partners.

Morgan Stanley has invested Rs1.6bn ($25.16m) as part of the financing round and will acquire a minority stake in the company.

Sahajanand plans to use the funds to expand its business operations and product portfolio.

“The investor company will hold an equity stake of 4.05% in Sandstone as a result of the transaction.”

Alliqua has signed an asset purchase agreement with biotechnology company Celularity Inc. Celularity Inc will acquire all the properties, assets, and rights relating to the Alliqua’s advanced biologic wound care business for $29m.

The transaction will enable Celularity to enhance its cell therapy and regenerative medicine business.

Both the companies involved in the transaction are regenerative technologies developers based in the US.

Canadian medical device company MedX Health Corp plans to raise C$1.5m ($1.2m) through the private placement of 12.5 million units priced at C$0.12 ($0.097) a unit.

Each unit consists of a common share and a common share purchase warrant, which permits the holder to acquire one additional share at a price of C$0.12 ($0.097) within three years of the offer closure.

Sandstone Diagnostics has secured a preferred equity investment of $1m from DPW Holdings Inc.

The investor company will hold an equity stake of 4.05% in Sandstone as a result of the transaction.

Based in the US, Sandstone is a diagnostic and digital health products developer, while DPW Holdings, also based in the US, is a diversified holding company.